Angelika Bekbulatova

Angelika Bekbulatova has extensive work experience in the field of pharmacovigilance and drug safety. Angelika started their career as a physician-intern at Simferopol Central Hospital in 1999, and later worked as a rheumatologist at Crimean Republican Clinical Hospital. In 2006, they became a medical interpreter/translator at STOPS Inc, providing interpretation and translation services for Russian and Ukrainian-speaking patients.

Angelika then transitioned to the pharmaceutical industry, working as a drug safety coordinator at Gilead Science Inc, where they were responsible for case processing and maintaining MedDRA search terms. Angelika joined Celgene as a safety review physician, focusing on oncology and rheumatology products and conducting safety assessments. At Otsuka Pharmaceutical Companies, Angelika served as a clinical safety physician, performing single case reviews and representing the company at various meetings.

In 2017, they joined The Janssen Pharmaceutical Companies of Johnson & Johnson as an associate director, safety surveillance physician. Angelika provided safety surveillance expertise and contributed to the department's scope of work.

Angelika'smost recent role was at Pfizer, where they worked as a global safety risk lead. In this position, they served as the point of contact for safety in asset teams, ensured unified communication on safety matters, and provided disease area-specific pharmacovigilance expertise. Angelika also identified opportunities for consistency and standards in safety surveillance and risk management, championed novel approaches, and engaged in continuous improvement initiatives.

Currently, Angelika Bekbulatova holds the position of a medical director of Pharmacovigilance at ImmunoGen, Inc, a company they joined in 2023.

Angelika Bekbulatova has a diverse education history. Angelika obtained their MD degree in medicine from Crimean Medical State University in 1999. Prior to that, they completed a Specialist degree in Internal Medicine in 2000 and a Specialist degree in Rheumatology in 2002, both at Crimean Medical State University. Angelika also pursued further education and earned a Certification in Clinical Trial Design and Management from San Francisco State University in 2009. Additionally, they obtained a Nursing, AA degree from Kherson Medical College between 1986 and 1989. Angelika has also obtained a certification in Clinical Trials Design & Management (Biotechnology) from San Francisco State University College of Extended Learning in 2009.